NCT00127504View on ClinicalTrials.gov

Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

May 31, 2004

Conditions
Onchocerciasis
Interventions
DRUG

Rifampin

DRUG

Azithromycin

Trial Locations (1)

Unknown

Universidad del Valle/MERTU, Guatemala City

All Listed Sponsors
collaborator

Universidad del Valle, Guatemala

OTHER

collaborator

University of Alabama at Birmingham

OTHER

lead

Centers for Disease Control and Prevention

FED

NCT00127504 - Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness | Biotech Hunter | Biotech Hunter